“cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies”-Reference-Cited by-同舟云学术

“cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies”

Published:2017-12-22 Issue: Volume: Page:1-12
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Cafaro Aurelio¹,Sgadari Cecilia¹,Picconi Orietta¹,Tripiciano Antonella¹,Moretti Sonia¹,Francavilla Vittorio¹,Pavone Cossut Maria Rosaria¹,Buttò Stefano¹,Cozzone Giovanni²,Ensoli Fabrizio³,Monini Paolo¹,Ensoli Barbara¹

Affiliation:

1. National HIV/AIDS Research Center, Istituto Superiore di Sanità, Rome, Italy

2. Vaxxit, Executive Office, Rome, Italy

3. Laboratory of Clinical Pathology and Microbiology, San Gallicano Institute, Istituti Fisioterapici Ospitalieri, Rome, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1418666

Reference74 articles.

1. The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+T Cells

2. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

3. Incomplete Peripheral CD4+Cell Count Restoration in HIV‐Infected Patients Receiving Long‐Term Antiretroviral Treatment

4. Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery

5. How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold Miners

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Tat: Role in Bystander Toxicity;Frontiers in Cellular and Infection Microbiology;2020-02-25

2. Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease;Vaccines;2019-08-26

3. Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption;PLOS ONE;2019-01-30

4. A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation;Nature Communications;2019-01-24